AA

Akash Adukia

Active Director Director DIN 03574729
DIN 03574729 First appointment Jul 2011 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 7 active board seats
Past companies 1 historical roles
Total affiliations 8 Since Jul 2011
Shareholding value •••• Premium profile

About Akash Adukia

Data last updated:

Akash Adukia is a Director at Orchid Medical Centre Private Limited (since 2014), Director at Ilika Estates Private Limited (since 2017) and Director at Park Avenue Fintrade Pvt.Ltd (since 2011), and holds 4 more current directorships. The companies operate in Healthcare, Real Estate and Construction and Financial Services. The 4 current companies with reported revenue have a combined latest revenue of ₹101 Cr; the largest is Orchid Medical Centre Private Limited at ₹84.93 Cr (FY 2024). Earlier, Akash Adukia was a Designated Partner at Panas Realtors Llp (2017–2018).

DIN 03574729
Primary Designation Director
Industry Healthcare
First Appointment 15 Jul 2011
Oldest Company Age 32 yrs
Largest company Orchid Medical Centre Private Limited · ₹84.93 Cr (FY 2024)
Combined revenue ₹101 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Sep 20142009₹84.93 Cr (FY 2024)Active
Ilika Estates Private Limited U45201WB2003PTC097181
Director25 Oct 20172003₹9.23 Cr (FY 2024)Active
Park Avenue Fintrade Pvt.Ltd U51109JH1995PTC017836
Director15 Jul 20111995₹6.07 Cr (FY 2025)Active
Bagmane Traders Pvt.Ltd U51109JH1994PTC013317
Director15 Jul 20111994₹41.2 Lakh (FY 2024)Active
Designated Partner30 Jun 20232023Active
Designated Partner01 Apr 20232016Active
Designated Partner28 Jun 20222022Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner18 Jan 20172017Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ilika Estates Private Limited
Bagmane Traders Pvt.Ltd
Park Avenue Fintrade Pvt.Ltd
Orchid Medical Centre Private Limited
Premium access

Shareholding and investment profile for Akash Adukia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akash Adukia

Akash Adukia currently holds 7 directorships: Orchid Medical Centre Private Limited (Director, since 25 Sep 2014, revenue ₹84.93 Cr (FY 2024)); Ilika Estates Private Limited (Director, since 25 Oct 2017, revenue ₹9.23 Cr (FY 2024)); Park Avenue Fintrade Pvt.Ltd (Director, since 15 Jul 2011, revenue ₹6.07 Cr (FY 2025)); Bagmane Traders Pvt.Ltd (Director, since 15 Jul 2011, revenue ₹41.2 Lakh (FY 2024)); Ilika Realtors Llp (Designated Partner, since 30 Jun 2023); and 2 more.

Akash Adukia was first appointed on 15 Jul 2011 as Director at Park Avenue Fintrade Pvt.Ltd. The most recent appointment on record is 30 Jun 2023 at Ilika Realtors Llp.

The 4 current companies of Akash Adukia that report revenue have a combined latest revenue of ₹101 Cr: Orchid Medical Centre Private Limited ₹84.93 Cr (FY 2024); Ilika Estates Private Limited ₹9.23 Cr (FY 2024); Park Avenue Fintrade Pvt.Ltd ₹6.07 Cr (FY 2025); Bagmane Traders Pvt.Ltd ₹41.2 Lakh (FY 2024).

Akash Adukia held 1 earlier board appointment: Panas Realtors Llp (Designated Partner, 18 Jan 2017 to 05 Feb 2018).

The current boards of Akash Adukia's companies include Anant Jain (Orchid Medical Centre Private Limited), Raj Kumar Agarwal (Orchid Medical Centre Private Limited), Subhash Chand Jain (Orchid Medical Centre Private Limited), Amit Agarwal (Ilika Estates Private Limited), Santosh Kumar Jain (Ilika Estates Private Limited), Bipin Agarwal (Park Avenue Fintrade Pvt.Ltd), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available